You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Ranbaxy Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for RANBAXY, and what generic and branded alternatives to RANBAXY drugs are available?

RANBAXY has forty-five approved drugs.

There are fifteen tentative approvals on RANBAXY drugs.

Summary for Ranbaxy

US Patents:	0
Tradenames:	33
Ingredients:	29
NDAs:	45
PTAB Cases with Ranbaxy as petitioner:	See PTAB cases with Ranbaxy as petitioner

Drugs and US Patents for Ranbaxy

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ranbaxy	CARBILEV	carbidopa; levodopa	TABLET, FOR SUSPENSION;ORAL	076643-002	Jun 10, 2005		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Ranbaxy Labs Ltd	GLIMEPIRIDE	glimepiride	TABLET;ORAL	076875-003	Oct 6, 2005		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Ranbaxy Labs Ltd	FLUCONAZOLE	fluconazole	TABLET;ORAL	076386-004	Jul 29, 2004		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Ranbaxy Labs Ltd	GLIMEPIRIDE	glimepiride	TABLET;ORAL	076875-001	Oct 6, 2005		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Ranbaxy	CARBILEV	carbidopa; levodopa	TABLET, FOR SUSPENSION;ORAL	076643-001	Jun 10, 2005		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Ranbaxy	DOXYCYCLINE HYCLATE	doxycycline hyclate	CAPSULE;ORAL	062479-001	Dec 23, 1983		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Ranbaxy

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Ranbaxy	AVENTYL	nortriptyline hydrochloride	SOLUTION;ORAL	014685-001	Approved Prior to Jan 1, 1982	3,922,305	⤷ Subscribe
Ranbaxy	RIOMET	metformin hydrochloride	SOLUTION;ORAL	021591-001	Sep 11, 2003	6,890,957	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.